Abstract
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have